Biotech News
Y-mAbs to Announce First Quarter 2025 Financial and Operating Results on May 13, 2025
ir.ymabs.com2026-05-06 15:01 EST
PRINCETON, N.J. , May 06, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the